Failure to thrive potentially secondary to maternal venlafaxine use

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists 2016-02, Vol.24 (1), p.98-99
Hauptverfasser: Tran, Michael MA, Fancourt, Nicholas, Ging, Joanne M, Tantsis, Esther M, Nelson, TY, Sharma, Reva
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 99
container_issue 1
container_start_page 98
container_title Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists
container_volume 24
creator Tran, Michael MA
Fancourt, Nicholas
Ging, Joanne M
Tantsis, Esther M
Nelson, TY
Sharma, Reva
description
doi_str_mv 10.1177/1039856215618528
format Article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1177_1039856215618528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1039856215618528</sage_id><sourcerecordid>10.1177_1039856215618528</sourcerecordid><originalsourceid>FETCH-LOGICAL-c304t-228c96705117149276cb7131a935395c11a7a7f4145afac738dec89f9ba0289c3</originalsourceid><addsrcrecordid>eNp1UE1Lw0AQXUSxtXr3JPkD0Z3d7NdRilWh4EXPYbqdaEqalN2k2H_vhqoHwdMMvA_ee4xdA78FMOYOuHRWaQFKg1XCnrApFAXPQWt1mv4E5yM-YRcxbjjniaTP2URoq7hTcsrmC6ybIVDWd1n_Eeo9Zbuup7avsWkOWSTftWsMhxHfYk-hxSbbU9tghZ91S9kQ6ZKdVdhEuvq-M_a2eHidP-XLl8fn-f0y95IXfS6E9U4brlJ0KJww2q8MSEAnlXTKA6BBUxVQqGTujbRr8tZVboVcWOfljPGjrw9djIGqchfqbQpXAi_HPcq_eyTJzVGyG1ZbWv8KfgZIhPxIiPhO5aYbxoLxf8MvK3JnNg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Failure to thrive potentially secondary to maternal venlafaxine use</title><source>Access via SAGE</source><source>MEDLINE</source><creator>Tran, Michael MA ; Fancourt, Nicholas ; Ging, Joanne M ; Tantsis, Esther M ; Nelson, TY ; Sharma, Reva</creator><creatorcontrib>Tran, Michael MA ; Fancourt, Nicholas ; Ging, Joanne M ; Tantsis, Esther M ; Nelson, TY ; Sharma, Reva</creatorcontrib><identifier>ISSN: 1039-8562</identifier><identifier>EISSN: 1440-1665</identifier><identifier>DOI: 10.1177/1039856215618528</identifier><identifier>PMID: 26850953</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Antidepressive Agents, Second-Generation - administration &amp; dosage ; Antidepressive Agents, Second-Generation - adverse effects ; Anxiety - drug therapy ; Body Weight ; Breast Feeding ; Depression - drug therapy ; Failure to Thrive - etiology ; Female ; Humans ; Infant, Newborn ; Pregnancy ; Venlafaxine Hydrochloride - administration &amp; dosage ; Venlafaxine Hydrochloride - adverse effects</subject><ispartof>Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists, 2016-02, Vol.24 (1), p.98-99</ispartof><rights>The Royal Australian and New Zealand College of Psychiatrists 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c304t-228c96705117149276cb7131a935395c11a7a7f4145afac738dec89f9ba0289c3</citedby><cites>FETCH-LOGICAL-c304t-228c96705117149276cb7131a935395c11a7a7f4145afac738dec89f9ba0289c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1039856215618528$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1039856215618528$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26850953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tran, Michael MA</creatorcontrib><creatorcontrib>Fancourt, Nicholas</creatorcontrib><creatorcontrib>Ging, Joanne M</creatorcontrib><creatorcontrib>Tantsis, Esther M</creatorcontrib><creatorcontrib>Nelson, TY</creatorcontrib><creatorcontrib>Sharma, Reva</creatorcontrib><title>Failure to thrive potentially secondary to maternal venlafaxine use</title><title>Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists</title><addtitle>Australas Psychiatry</addtitle><subject>Antidepressive Agents, Second-Generation - administration &amp; dosage</subject><subject>Antidepressive Agents, Second-Generation - adverse effects</subject><subject>Anxiety - drug therapy</subject><subject>Body Weight</subject><subject>Breast Feeding</subject><subject>Depression - drug therapy</subject><subject>Failure to Thrive - etiology</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Pregnancy</subject><subject>Venlafaxine Hydrochloride - administration &amp; dosage</subject><subject>Venlafaxine Hydrochloride - adverse effects</subject><issn>1039-8562</issn><issn>1440-1665</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UE1Lw0AQXUSxtXr3JPkD0Z3d7NdRilWh4EXPYbqdaEqalN2k2H_vhqoHwdMMvA_ee4xdA78FMOYOuHRWaQFKg1XCnrApFAXPQWt1mv4E5yM-YRcxbjjniaTP2URoq7hTcsrmC6ybIVDWd1n_Eeo9Zbuup7avsWkOWSTftWsMhxHfYk-hxSbbU9tghZ91S9kQ6ZKdVdhEuvq-M_a2eHidP-XLl8fn-f0y95IXfS6E9U4brlJ0KJww2q8MSEAnlXTKA6BBUxVQqGTujbRr8tZVboVcWOfljPGjrw9djIGqchfqbQpXAi_HPcq_eyTJzVGyG1ZbWv8KfgZIhPxIiPhO5aYbxoLxf8MvK3JnNg</recordid><startdate>201602</startdate><enddate>201602</enddate><creator>Tran, Michael MA</creator><creator>Fancourt, Nicholas</creator><creator>Ging, Joanne M</creator><creator>Tantsis, Esther M</creator><creator>Nelson, TY</creator><creator>Sharma, Reva</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201602</creationdate><title>Failure to thrive potentially secondary to maternal venlafaxine use</title><author>Tran, Michael MA ; Fancourt, Nicholas ; Ging, Joanne M ; Tantsis, Esther M ; Nelson, TY ; Sharma, Reva</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c304t-228c96705117149276cb7131a935395c11a7a7f4145afac738dec89f9ba0289c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antidepressive Agents, Second-Generation - administration &amp; dosage</topic><topic>Antidepressive Agents, Second-Generation - adverse effects</topic><topic>Anxiety - drug therapy</topic><topic>Body Weight</topic><topic>Breast Feeding</topic><topic>Depression - drug therapy</topic><topic>Failure to Thrive - etiology</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Pregnancy</topic><topic>Venlafaxine Hydrochloride - administration &amp; dosage</topic><topic>Venlafaxine Hydrochloride - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tran, Michael MA</creatorcontrib><creatorcontrib>Fancourt, Nicholas</creatorcontrib><creatorcontrib>Ging, Joanne M</creatorcontrib><creatorcontrib>Tantsis, Esther M</creatorcontrib><creatorcontrib>Nelson, TY</creatorcontrib><creatorcontrib>Sharma, Reva</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tran, Michael MA</au><au>Fancourt, Nicholas</au><au>Ging, Joanne M</au><au>Tantsis, Esther M</au><au>Nelson, TY</au><au>Sharma, Reva</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Failure to thrive potentially secondary to maternal venlafaxine use</atitle><jtitle>Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists</jtitle><addtitle>Australas Psychiatry</addtitle><date>2016-02</date><risdate>2016</risdate><volume>24</volume><issue>1</issue><spage>98</spage><epage>99</epage><pages>98-99</pages><issn>1039-8562</issn><eissn>1440-1665</eissn><cop>London, England</cop><pub>SAGE Publications</pub><pmid>26850953</pmid><doi>10.1177/1039856215618528</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1039-8562
ispartof Australasian psychiatry : bulletin of the Royal Australian and New Zealand College of Psychiatrists, 2016-02, Vol.24 (1), p.98-99
issn 1039-8562
1440-1665
language eng
recordid cdi_crossref_primary_10_1177_1039856215618528
source Access via SAGE; MEDLINE
subjects Antidepressive Agents, Second-Generation - administration & dosage
Antidepressive Agents, Second-Generation - adverse effects
Anxiety - drug therapy
Body Weight
Breast Feeding
Depression - drug therapy
Failure to Thrive - etiology
Female
Humans
Infant, Newborn
Pregnancy
Venlafaxine Hydrochloride - administration & dosage
Venlafaxine Hydrochloride - adverse effects
title Failure to thrive potentially secondary to maternal venlafaxine use
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A51%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Failure%20to%20thrive%20potentially%20secondary%20to%20maternal%20venlafaxine%20use&rft.jtitle=Australasian%20psychiatry%20:%20bulletin%20of%20the%20Royal%20Australian%20and%20New%20Zealand%20College%20of%20Psychiatrists&rft.au=Tran,%20Michael%20MA&rft.date=2016-02&rft.volume=24&rft.issue=1&rft.spage=98&rft.epage=99&rft.pages=98-99&rft.issn=1039-8562&rft.eissn=1440-1665&rft_id=info:doi/10.1177/1039856215618528&rft_dat=%3Csage_cross%3E10.1177_1039856215618528%3C/sage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26850953&rft_sage_id=10.1177_1039856215618528&rfr_iscdi=true